Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Ventyx Biosciences, Inc. (VTYX) had Normalized Pre-Tax Income of $-26.99M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-26.99M |
|
-- |
|
-- |
|
$29.33M |
|
$-29.33M |
|
$2.35M |
|
$-26.99M |
|
|
Normalized Pre-Tax Income |
$-26.99M |
$-26.99M |
|
$-26.99M |
|
$-26.99M |
|
$-26.99M |
|
$-29.33M |
|
$-29.01M |
|
71.20M |
|
71.20M |
|
$-0.38 |
|
$-0.38 |
|
| Balance Sheet Financials | |
$219.32M |
|
$0.55M |
|
$10.69M |
|
$230.01M |
|
$11.47M |
|
-- |
|
$9.16M |
|
$20.63M |
|
$209.38M |
|
$209.38M |
|
$209.38M |
|
71.23M |
|
| Cash Flow Statement Financials | |
$-46.99M |
|
$51.61M |
|
$0.07M |
|
$28.23M |
|
$33.28M |
|
$5.04M |
|
$9.61M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
19.12 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-47.05M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-12.89% |
|
-12.89% |
|
-11.73% |
|
-12.89% |
|
$2.94 |
|
$-0.66 |
|
$-0.66 |
|